Simon Schwartz Navarro Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools. Instituciones de las que forman parte Investigador/a principal Bioquímica Clínica, Vehiculización de Fármacos y Terapia Vall Hebron Institut de Recerca Cap de Secció Bioquímica Serveis transversals LinkedIn Twitter Orcid Simon Schwartz Navarro LinkedIn Twitter Orcid Instituciones de las que forman parte Investigador/a principal Bioquímica Clínica, Vehiculización de Fármacos y Terapia Vall Hebron Institut de Recerca Cap de Secció Bioquímica Serveis transversals Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools.
Senior research of the clinical biochemistry - drug delivery and therapy group at VHIR and Strategy director of biobanking and biomodels at Vall d'hebron Campus. President of the European Society of Nanomedicine and Executive Board member of the International Society of Nanomedicine. Former director general of the Blood and Tissue Banc of Catalonia. Former director of CIBBIM-Nanomedicine. Former scientific associate director of CIBER-BBN and coordinator of technology transfer. Former director assistance of translational research at VHIR. H-index of 48, with more that 120 high impact publications, 19 transferred patents and several EU granted projects. Co-founder of 3 biotech companies (i.e, Bsure Medical ltd). Science Advisor of the European Nanomedicine Characterization Laboratory (EU-NCL). Member of the editorial Board of Precision Nanomedicine, J. Nanotechnology and of J. of Nanotheranostics. Former editorial Board member of Eur. J. Nanomedicine and Nanomedicine-NBM. Exper member of the nanomedicine group at EMA.
Proyectos Development of nanomedicines for enzymatic replacement therapy in Fabry disease IP: Simon Schwartz Navarro Colaboradores: Development of nanomedicines for enzymatic replacement therapy in Fabry disease Entidad financiadora: Fundació La Marató de TV3 Financiación: 214925 Referencia: MARATV3/2010/101230 Duración: 03/02/2011 - 31/12/2014 NANOSTEM-Acción complementaria IP: Simon Schwartz Navarro Colaboradores: - Entidad financiadora: Ministerio de Ciencia e Innovación-MICINN Financiación: 3000 Referencia: SAF2009-08592-E Duración: 01/11/2009 - 30/04/2010 Targetting Combined Therapy to Cancer Stem Cells (Nanoquest) IP: Simon Schwartz Navarro Colaboradores: - Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca Financiación: 4680.44 Referencia: 2009LID2-C-20 Duración: 01/01/2010 - 20/01/2010 Activación de vías dependientes del oncogen BRAF en la tumorogénesis y metástasis del cáncer colorectal en modelos in vivo IP: Simon Schwartz Navarro Colaboradores: Activación de vías dependientes del oncogen BRAF en la tumorogénesis y metástasis del cáncer colorectal en modelos in vivo Entidad financiadora: Instituto de Salud Carlos III Financiación: 219252 Referencia: PI080771 Duración: 01/01/2009 - 30/06/2012 Paginación Primera página « Página anterior ‹ … Página 6 Página 7 Página actual 8 Página 9 Página 10 … Siguiente página › Última página »
